Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients
NCT06406179Active, not recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2025
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Estimated Glomerular Filtration Rate at 18 months. Started May 2025; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06406179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406179.